Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs AUROBINDO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES AUROBINDO PHARMA DIVIS LABORATORIES/
AUROBINDO PHARMA
 
P/E (TTM) x 66.3 22.9 289.9% View Chart
P/BV x 7.2 2.4 303.4% View Chart
Dividend Yield % 0.9 0.3 313.9%  

Financials

 DIVIS LABORATORIES   AUROBINDO PHARMA
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-23
AUROBINDO PHARMA
Mar-23
DIVIS LABORATORIES/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs4,641715 649.4%   
Low Rs2,730397 687.1%   
Sales per share (Unadj.) Rs292.6424.2 69.0%  
Earnings per share (Unadj.) Rs68.732.9 208.8%  
Cash flow per share (Unadj.) Rs81.654.1 150.7%  
Dividends per share (Unadj.) Rs30.003.00 1,000.0%  
Avg Dividend yield %0.80.5 150.8%  
Book value per share (Unadj.) Rs480.9458.1 105.0%  
Shares outstanding (eoy) m265.47585.94 45.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x12.61.3 961.1%   
Avg P/E ratio x53.716.9 317.5%  
P/CF ratio (eoy) x45.210.3 439.8%  
Price / Book Value ratio x7.71.2 631.4%  
Dividend payout %43.79.1 479.0%   
Avg Mkt Cap Rs m978,378325,753 300.3%   
No. of employees `000NANA-   
Total wages/salary Rs m9,75035,223 27.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m77,675248,554 31.3%  
Other income Rs m3,4472,906 118.6%   
Total revenues Rs m81,122251,460 32.3%   
Gross profit Rs m23,69137,070 63.9%  
Depreciation Rs m3,43212,446 27.6%   
Interest Rs m201,405 1.4%   
Profit before tax Rs m23,68626,125 90.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,4536,849 79.6%   
Profit after tax Rs m18,23419,277 94.6%  
Gross profit margin %30.514.9 204.5%  
Effective tax rate %23.026.2 87.8%   
Net profit margin %23.57.8 302.7%  
BALANCE SHEET DATA
Current assets Rs m97,437214,599 45.4%   
Current liabilities Rs m15,331114,938 13.3%   
Net working cap to sales %105.740.1 263.6%  
Current ratio x6.41.9 340.4%  
Inventory Days Days821 40.6%  
Debtors Days Days84266 1,284.2%  
Net fixed assets Rs m51,128176,668 28.9%   
Share capital Rs m531586 90.6%   
"Free" reserves Rs m127,140267,813 47.5%   
Net worth Rs m127,671268,399 47.6%   
Long term debt Rs m06,190 0.0%   
Total assets Rs m148,565392,125 37.9%  
Interest coverage x1,209.519.6 6,171.8%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.50.6 82.5%   
Return on assets %12.35.3 233.0%  
Return on equity %14.37.2 198.9%  
Return on capital %18.610.0 185.2%  
Exports to sales %85.733.7 254.4%   
Imports to sales %19.815.3 129.3%   
Exports (fob) Rs m66,53783,703 79.5%   
Imports (cif) Rs m15,37838,060 40.4%   
Fx inflow Rs m66,53785,483 77.8%   
Fx outflow Rs m15,71541,447 37.9%   
Net fx Rs m50,82244,036 115.4%   
CASH FLOW
From Operations Rs m24,59723,868 103.1%  
From Investments Rs m-27,076-39,778 68.1%  
From Financial Activity Rs m-7,97218,144 -43.9%  
Net Cashflow Rs m-10,4512,298 -454.8%  

Share Holding

Indian Promoters % 51.9 48.8 106.5%  
Foreign collaborators % 0.0 3.1 -  
Indian inst/Mut Fund % 36.7 41.3 88.9%  
FIIs % 14.9 20.7 71.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.1 48.2 99.8%  
Shareholders   354,482 241,944 146.5%  
Pledged promoter(s) holding % 0.0 20.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Divis Laboratories vs Aurobindo Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Divis Laboratories vs Aurobindo Pharma Share Price Performance

Period Divis Laboratories Aurobindo Pharma S&P BSE HEALTHCARE
1-Day 2.69% 1.36% 1.22%
1-Month -1.62% 5.49% -0.71%
1-Year 23.16% 112.12% 61.88%
3-Year CAGR -1.20% 7.62% 18.17%
5-Year CAGR 15.89% 7.09% 19.80%

* Compound Annual Growth Rate

Here are more details on the Divis Laboratories share price and the Aurobindo Pharma share price.

Moving on to shareholding structures...

The promoters of Divis Laboratories hold a 51.9% stake in the company. In case of Aurobindo Pharma the stake stands at 51.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Divis Laboratories and the shareholding pattern of Aurobindo Pharma.

Finally, a word on dividends...

In the most recent financial year, Divis Laboratories paid a dividend of Rs 30.0 per share. This amounted to a Dividend Payout ratio of 43.7%.

Aurobindo Pharma paid Rs 3.0, and its dividend payout ratio stood at 9.1%.

You may visit here to review the dividend history of Divis Laboratories, and the dividend history of Aurobindo Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.